Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

GUTSFRACTYL HEALTH, INC.

Nasdaq · CIK 0001572616
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end1231
XBRL facts164

Identity from submissions API

NameFRACTYL HEALTH, INC.
CIK0001572616
TickersGUTS
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC3841 Surgical & Medical Instruments & Apparatus
EIN273553477
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone781-902-8800
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Fractyl Laboratories Inc. (2013-03-21T00:00:00.000Z → 2020-03-19T00:00:00.000Z)
Business address
3 VAN DE GRAAFF DRIVE
SUITE 200
BURLINGTON
MA
01803
MA
Mailing address
3 VAN DE GRAAFF DRIVE
SUITE 200
BURLINGTON
MA
01803
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

233 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 8-K/A 8-K/A 5.02,9.01 0001193125-26-468664 001-41942 261575321 34 372242 1 1
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127208 005-94430 261553865 34 12107
2026-11-12 10-Q 10-Q 0001193125-26-458318 001-41942 261546819 34 7754470 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458308 001-41942 261546773 34 446241 1 1
2026-11-06 3 3 0001193125-26-452006 23575
2026-11-06 8-K 8-K 5.02,9.01 0001193125-26-451917 001-41942 261532455 34 292172 1 1
2026-10-22 8-K 8-K 2.05,5.02,8.01,9.01 0001193125-26-428302 001-41942 261477185 34 238821 1 1
2026-10-16 8-K 8-K 7.01,8.01,9.01 0001193125-26-423377 001-41942 261464325 34 14775253 1 1
2026-10-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001958125-26-000008 005-94430 261456303 34 12211
2026-10-01 8-K 8-K 5.03,9.01 0001193125-26-409747 001-41942 261428885 34 192704 1 1
2026-09-24 8-K 8-K 5.07 0001193125-26-401050 001-41942 261404938 34 156353 1 1
2026-09-16 4 4 0001193125-26-393052 4839
2026-09-11 8-K 8-K 3.01 0001193125-26-389291 001-41942 261374534 34 159130 1 1
2026-08-24 DEF 14A DEF 14A 0001193125-26-363587 001-41942 261310610 34 2510667 1 1
2026-08-14 PRE 14A PRE 14A 0001193125-26-352234 001-41942 261281571 34 2230900 1 1
2026-08-10 10-Q 10-Q 0001193125-26-342345 001-41942 261258359 34 7118516 1 1
2026-08-10 8-K 8-K 2.02,9.01 0001193125-26-342343 001-41942 261258339 34 400834 1 1
2026-07-15 8-K 8-K 7.01,8.01,9.01 0001193125-26-303948 001-41942 261175772 34 13185277 1 1
2026-06-15 4 4 0001193125-26-271386 7527
2026-06-11 8-K 8-K 5.07 0001193125-26-267897 001-41942 261084114 34 162596 1 1
2026-06-11 4 4 0001193125-26-267851 7426
2026-06-11 4 4 0001193125-26-267849 5906
2026-06-11 4 4 0001193125-26-267847 5879
2026-06-11 4 4 0001193125-26-267844 5910
2026-06-11 4 4 0001193125-26-267843 5923
2026-06-11 4 4 0001193125-26-267842 5925
2026-06-11 4 4 0001193125-26-267839 5893
2026-06-11 4 4 0001193125-26-267838 7385
2026-06-11 4 4 0001193125-26-267833 7855
2026-06-09 4 4 0001193125-26-264430 5567
2026-06-04 8-K 8-K 7.01,8.01,9.01 0001193125-26-256445 001-41942 261063198 34 324400 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062679 005-94430 26988808 34 11344
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001404574-26-000015 005-94430 26983644 34 11068
2026-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-060268 005-94430 26973657 34 8539
2026-05-12 10-Q 10-Q 0001193125-26-219373 001-41942 26968434 34 6534343 1 1
2026-05-12 8-K 8-K 2.02,9.01 0001193125-26-219365 001-41942 26968406 34 333697 1 1
2026-05-11 8-K 8-K 7.01,9.01 0001193125-26-215662 001-41942 26960809 34 186373 1 1
2026-04-24 ARS ARS 0001193125-26-177289 001-41942 26894140 34 5567533
2026-04-24 DEFA14A DEFA14A 0001193125-26-177245 001-41942 26893847 34 3444819
2026-04-24 DEF 14A DEF 14A 0001193125-26-177134 001-41942 26893544 34 6471398 1 1
2026-03-24 10-K 10-K 0001193125-26-121793 001-41942 26786186 34 43227651 1 1
2026-03-24 8-K 8-K 2.02,7.01,9.01 0001193125-26-121780 001-41942 26786085 34 558776 1 1
2026-03-17 8-K 8-K 3.01 0001193125-26-110923 001-41942 26762429 34 154632 1 1
2026-02-26 8-K 8-K 7.01,9.01 0001193125-26-073374 001-41942 26681663 34 197050 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001173 005-94430 26642589 34 11041
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-048781 005-94430 26626477 34 22868
2026-02-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-037247 005-94430 26597296 34 8910
2026-01-29 8-K 8-K 7.01,8.01,9.01 0001193125-26-028228 001-41942 26574871 34 10082783 1 1
2026-01-14 4 4 0001193125-26-012975 5700
2026-01-14 3 3 0001193125-26-012932 22556
2026-01-13 S-8 S-8 0001193125-26-011901 333-292715 26531085 33 472994 1 1
2026-01-06 8-K 8-K 5.02,7.01,9.01 0001193125-26-003452 001-41942 26509383 34 632883 1 1
2026-01-05 8-K 8-K 2.02,8.01,9.01 0001193125-26-001492 001-41942 26503879 34 216643 1 1
2025-12-17 4 4 0001193125-25-323019 5614
2025-12-17 4 4 0001193125-25-323018 5636
2025-12-17 4 4 0001193125-25-323017 5615
2025-12-16 8-K 8-K 7.01,8.01,9.01 0001193125-25-319524 001-41942 251572765 34 257839 1 1
2025-12-08 4 4 0001193125-25-310558 7109
2025-12-02 8-K 8-K 7.01,8.01,9.01 0001193125-25-304486 001-41942 251541559 34 433841 1 1
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005139 005-94430 251488502 34 10840
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112680 005-94430 251487574 34 11122
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001012975-25-000774 005-94430 251487029 34 12096
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112182 005-94430 251483720 34 10575
2025-11-12 10-Q 10-Q 0001193125-25-277531 001-41942 251472618 34 11024866 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001193125-25-277524 001-41942 251472604 34 955422 1 1
2025-10-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001085146-25-005954 005-94430 251392299 34 11747
2025-10-03 8-K 8-K 5.07 0001193125-25-230096 001-41942 251373754 34 159006 1 1
2025-09-26 424B5 424B5 0001193125-25-220768 333-285522 251351323 33 612722
2025-09-26 8-K 8-K 1.01,7.01,9.01 0001193125-25-218515 001-41942 251345415 34 454778 1 1
2025-09-26 8-K 8-K 7.01,8.01,9.01 0001193125-25-218508 001-41942 251345407 34 6878493 1 1
2025-09-04 4 4 0000950170-25-113125 5645
2025-09-04 3 3 0000950170-25-113121 24624
2025-09-04 4 4 0000950170-25-113112 5602
2025-09-04 3 3 0000950170-25-113109 23409
2025-09-03 8-K 8-K 5.02 0000950170-25-112671 001-41942 251287730 34 156921 1 1
2025-08-25 DEF 14A DEF 14A 0001140361-25-032517 001-41942 251251360 34 2009941
2025-08-15 PRE 14A PRE 14A 0001140361-25-031510 001-41942 251224706 34 1908567
2025-08-12 10-Q 10-Q 0000950170-25-107297 001-41942 251206614 34 8188795 1 1
2025-08-12 8-K 8-K 2.02,9.01 0000950170-25-107295 001-41942 251206611 34 960001 1 1
2025-08-07 8-K 8-K 1.01,9.01 0001193125-25-175581 001-41942 251195433 34 833390 1 1
2025-08-07 424B5 424B5 0001193125-25-174719 333-285522 251191286 33 634522
2025-08-05 424B5 424B5 0001193125-25-173586 333-285522 251185756 33 662219
2025-06-23 8-K 8-K 7.01,8.01,9.01 0000950170-25-088710 001-41942 251062978 34 267292 1 1
2025-06-18 8-K 8-K 7.01,8.01,9.01 0000950170-25-087678 001-41942 251055118 34 184530 1 1
2025-06-13 4 4 0000950170-25-086148 5765
2025-06-13 4 4 0000950170-25-086154 5768
2025-06-13 4 4 0000950170-25-086153 5738
2025-06-13 4 4 0000950170-25-086152 5753
2025-06-13 4 4 0000950170-25-086151 5755
2025-06-13 4 4 0000950170-25-086144 5723
2025-06-13 4 4 0000950170-25-086149 5751
2025-06-12 8-K 8-K 5.07 0000950170-25-085375 001-41942 251042746 34 162643 1 1
2025-05-19 8-K 8-K 7.01,9.01 0000950170-25-073988 001-41942 25961839 34 189441 1 1
2025-05-19 8-K 8-K 7.01,9.01 0000950170-25-073945 001-41942 25961470 34 213733 1 1
2025-05-13 8-K 8-K 2.02,9.01 0000950170-25-070294 001-41942 25939931 34 905135 1 1
2025-05-13 10-Q 10-Q 0000950170-25-070275 001-41942 25939775 34 7325721 1 1
2025-04-24 ARS ARS 0001140361-25-015437 001-41942 25867396 34 23907738
2025-04-24 DEFA14A DEFA14A 0001140361-25-015433 001-41942 25867335 34 2014660
2025-04-24 DEF 14A DEF 14A 0001140361-25-015422 001-41942 25867265 34 4503692 1 1
2025-04-23 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-000435 005-94430 25859895 34 11260
2025-04-01 8-K 8-K 7.01,8.01,9.01 0000950170-25-048033 001-41942 25796536 34 194342 1 1
2025-03-18 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000716 333-285522 25750699 33 1999
2025-03-18 4/A 4/A 0000950170-25-041650 4215
2025-03-18 4 4 0000950170-25-041633 7848
2025-03-18 4 4 0000950170-25-041324 4564
2025-03-17 4 4 0000950170-25-040466 5132
2025-03-17 4 4 0000950170-25-040139 5127
2025-03-17 4 4 0000950170-25-040138 5118
2025-03-13 CORRESP filename1.htm 0001193125-25-054192 7518
2025-03-13 S-3/A S-3/A 0001193125-25-054048 333-285522 25736894 33 518030
2025-03-13 8-K 8-K 5.08,8.01 0000950170-25-038683 001-41942 25735596 34 158858 1 1
2025-03-11 UPLOAD filename1.pdf 0000000000-25-002685 333-285522 40416
2025-03-03 4 4 0000950170-25-031269 8327
2025-03-03 4 4 0000950170-25-031268 8313
2025-03-03 4 4 0000950170-25-031266 8375
2025-03-03 4 4 0000950170-25-031262 8296
2025-03-03 4 4 0000950170-25-031260 8348
2025-03-03 S-3 S-3 0001193125-25-044297 333-285522 25699715 33 1100206
2025-03-03 8-K 8-K 2.02,9.01 0000950170-25-030826 001-41942 25697743 34 963765 1 1
2025-03-03 10-K 10-K 0000950170-25-030807 001-41942 25697625 34 34688876 1 1
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021435 005-94430 25630801 34 189388
2025-02-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-000631 005-94430 25587823 34 11934
2025-02-03 4 4 0000950170-25-012531 16277
2025-02-03 4 4 0000950170-25-012530 15501
2025-01-31 8-K 8-K 2.05,7.01,9.01 0000950170-25-011430 001-41942 25575960 34 220884 1 1
2025-01-30 144 xsl144X01/primary_doc.xml 0001950047-25-000493 001-41942 25573872 33 6154
2025-01-30 144 xsl144X01/primary_doc.xml 0001950047-25-000492 001-41942 25573870 33 6000
2025-01-13 8-K 8-K 7.01,9.01 0000950170-25-004554 001-41942 25524757 34 190765 1 1
2024-11-14 SC 13G SC 13G 0001193125-24-258660 005-94430 241463149 34 79296
2024-11-13 4 4 0000950170-24-126560 10656
2024-11-13 4 4 0000950170-24-126558 9879
2024-11-13 SC 13G SC 13G 0001193125-24-257370 005-94430 241455693 34 143059
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-125329 001-41942 241447922 34 584701 1 1
2024-11-12 10-Q 10-Q 0000950170-24-125293 001-41942 241447707 34 7866759 1 1
2024-11-04 8-K 8-K 7.01,9.01 0000950170-24-120706 001-41942 241423728 34 192598 1 1
2024-09-13 4 4 0000950170-24-106530 10001
2024-09-12 144 xsl144X01/primary_doc.xml 0001950047-24-007016 001-41942 241295482 33 4939
2024-08-14 8-K 8-K 2.02,9.01 0000950170-24-096983 001-41942 241207453 34 591402 1 1
2024-08-14 10-Q 10-Q 0000950170-24-096968 001-41942 241207188 34 7500758 1 1
2024-07-30 8-K 8-K 7.01,9.01 0000950170-24-087501 001-41942 241154349 34 193603 1 1
2024-06-24 8-K 8-K 7.01,9.01 0000950170-24-076424 001-41942 241061893 34 203099 1 1
2024-05-14 3/A FORM 3/A SUBMISSION 0000899243-24-000274 24766
2024-05-13 10-Q 10-Q 0000950170-24-058634 001-41942 24939013 34 9138239 1 1
2024-05-13 8-K 8-K 2.02,9.01 0000950170-24-058615 001-41942 24938853 34 549324 1 1
2024-04-02 4 4 0000950170-24-040179 5631
2024-04-02 3 3 0000950170-24-040163 20132
2024-04-01 10-K 10-K 0000950170-24-038866 001-41942 24805522 34 13811425
2024-04-01 8-K 8-K 2.02,9.01 0000950170-24-038865 001-41942 24805515 34 609830 1 1
2024-04-01 8-K 8-K 7.01,9.01 0001193125-24-082586 001-41942 24805407 34 209300 1 1
2024-02-16 SC 13G SC 13G 0001193125-24-038760 005-94430 24650413 34 97689
2024-02-14 SC 13G SC 13G 0001193125-24-036111 005-94430 24637522 34 50564
2024-02-08 4 xslF345X05/form4-02082024_100252.xml 0001415889-24-003067 29902
2024-02-08 4 OWNERSHIP DOCUMENT 0001104659-24-012332 30108
2024-02-08 4 OWNERSHIP DOCUMENT 0001104659-24-012331 10014
2024-02-08 4 OWNERSHIP DOCUMENT 0001104659-24-012328 9597
2024-02-08 4 4 0000950170-24-012842 7499
2024-02-08 4 4 0000950170-24-012838 20152
2024-02-08 4 4 0000950170-24-012836 15146
2024-02-08 4 4 0000950170-24-012835 11142
2024-02-08 4 4 0000950170-24-012830 28741
2024-02-08 4 4 0000950170-24-012828 39367
2024-02-08 4 4 0000950170-24-012819 11463
2024-02-08 4 xslF345X05/e619233_4-flynn.xml 0001193805-24-000147 24793
2024-02-06 4 FORM 4 SUBMISSION 0000899243-24-000153 21530
2024-02-06 S-8 FORM S-8 0001193125-24-025300 333-276897 24600656 33 114393
2024-02-06 8-K FORM 8-K 5.03,8.01,9.01 0001193125-24-025262 001-41942 24600240 34 402628 1 1
2024-02-05 4 4 0000950170-24-011345 5190
2024-02-05 4 4 0000950170-24-011341 5146
2024-02-05 4 4 0000950170-24-011339 5181
2024-02-05 4 4 0000950170-24-011340 5160
2024-02-05 4 4 0000950170-24-011333 5177
2024-02-05 4 4 0000950170-24-011331 5173
2024-02-05 4 4 0000950170-24-011325 5175
2024-02-05 4 4 0000950170-24-011323 5187
2024-02-02 424B4 424B4 0001193125-24-022867 333-276046 24591691 33 8207402
2024-02-01 SEC STAFF LETTER filename1.pdf 9999999997-24-000232 63954
2024-02-01 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-02-01 16:00:00 9999999995-24-000282 333-276046 24588674 33 1848
2024-02-01 3 3 0000950170-24-009979 94748
2024-02-01 3 xslF345X02/doc3.xml 0001225208-24-001418 6403
2024-02-01 3 xslF345X02/doc3.xml 0001225208-24-001417 5984
2024-02-01 3 xslF345X02/doc3.xml 0001225208-24-001416 14863
2024-02-01 3 xslF345X02/form3-02022024_120208.xml 0001415889-24-002218 20818
2024-02-01 3 FORM 3 SUBMISSION 0000899243-24-000140 13993
2024-02-01 3 xslF345X02/e619223_3-fh.xml 0001193805-24-000121 18940
2024-02-01 3 3 0000950170-24-009930 40044
2024-02-01 3 3 0000950170-24-009925 25839
2024-02-01 3 3 0000950170-24-009920 21838
2024-02-01 3 3 0000950170-24-009918 22730
2024-02-01 3 3 0000950170-24-009917 30357
2024-02-01 3 3 0000950170-24-009914 19194
2024-02-01 3 3 0000950170-24-009912 22593
2024-02-01 3 3 0000950170-24-009911 36995
2024-02-01 3 3 0000950170-24-009903 35320
2024-02-01 3 3 0000950170-24-009901 27679
2024-02-01 3 3 0000950170-24-009900 25175
2024-02-01 3 3 0000950170-24-009899 25895
2024-02-01 3 3 0000950170-24-009897 19718
2024-02-01 3 3 0000950170-24-009895 22073
2024-02-01 CERT GUTS_8A_Cert.pdf 0001354457-24-000045 001-41942 24586569 34 213508
2024-01-30 CORRESP filename1.htm 0001193125-24-019538 10918
2024-01-30 CORRESP filename1.htm 0001193125-24-019534 7581
2024-01-29 8-A12B 8-A12B 0001193125-24-018101 001-41942 24573647 34 13909
2024-01-29 CORRESP filename1.htm 0001193125-24-017326 22775
2024-01-29 S-1/A S-1/A 0001193125-24-017309 333-276046 24569981 33 9709090
2023-12-20 UPLOAD filename1.pdf 0000000000-23-013915 377-05668 43835
2023-12-19 SEC STAFF LETTER filename1.pdf 9999999997-23-004777 64903
2023-12-14 CORRESP filename1.htm 0001193125-23-295434 25777
2023-12-14 S-1 FORM S-1 0001193125-23-295433 333-276046 231486942 33 11657094
2023-10-03 UPLOAD filename1.pdf 0000000000-23-010905 377-05668 43498
2023-09-21 DRS/A filename1.htm 0000950123-23-008585 377-05668 231269815 33 7883764
2023-09-21 DRSLTR filename1.htm 0000950123-23-008584 28167
2023-09-15 UPLOAD filename1.pdf 0000000000-23-010221 377-05668 45973
2023-08-22 DRS/A filename1.htm 0000950123-23-008325 377-05668 231194493 33 7569411
2022-04-04 DRS/A filename1.htm 0000950123-22-003738 377-05668 22803679 33 6813465
2022-02-03 DRSLTR filename1.htm 0000950123-22-000926 26226
2022-02-03 DRS/A filename1.htm 0000950123-22-000925 377-05668 22589820 33 9005262
2022-01-25 D xslFormDX01/primary_doc.xml 06b 0001567619-22-001666 021-430685 22552062 33 13992
2022-01-13 UPLOAD filename1.pdf 0000000000-22-000497 377-05668 44071
2022-01-12 DRS/A filename1.htm 0000950123-22-000182 377-05668 22525394 33 8933680
2022-01-11 DRSLTR filename1.htm 0000950123-22-000183 33913
2022-01-05 UPLOAD filename1.pdf 0000000000-22-000080 377-05668 49894
2021-12-20 DRSLTR filename1.htm 0000950123-21-016346 55133
2021-12-20 DRS/A filename1.htm 0000950123-21-016345 377-05668 211505967 33 6596384
2021-12-14 UPLOAD filename1.pdf 0000000000-21-014936 377-05668 61245
2021-11-09 DRS filename1.htm 0000950123-21-014347 377-05668 211391637 33 6536823
2021-06-22 D xslFormDX01/primary_doc.xml 06b 0001567619-21-012463 021-403725 211033976 33 14774
2020-03-19 D xslFormDX01/primary_doc.xml 06b 0001567619-20-006726 021-363219 20726829 33 14758
2017-12-15 D/A xslFormDX01/primary_doc.xml 06b 0001625257-17-000118 021-289968 171258389 33 12872
2017-07-05 D xslFormDX01/primary_doc.xml 06b 0001140361-17-027017 021-289968 17946360 33 11844
2016-02-19 D/A xslFormDX01/primary_doc.xml 06b 0001140361-16-054111 021-250810 161441152 33 10934
2015-11-06 D xslFormDX01/primary_doc.xml 06b 0001140361-15-039925 021-250810 151202964 33 10751
2014-09-03 D xslFormDX01/primary_doc.xml 06b 0001572616-14-000002 021-223992 141079360 33 11621
2013-03-21 D xslFormDX01/primary_doc.xml 06 0001572616-13-000001 021-193726 13707313 33 10856

Latest XBRL company facts

One latest value per concept from companyfacts (164 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 13.26M 2026-11-02 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
dei EntityPublicFloat Entity Public Float USD 49.60M 2025-06-30 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 9.99M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.73M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030807
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 4.38M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277531
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 861,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.72M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 573.52M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.39M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 17,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 7.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 3.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap Assets Assets USD 65.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap AssetsCurrent Assets, Current USD 34.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 32,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277531
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 31.52M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 35.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -50.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 49.68M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 13.26M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 13.26M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap ContractualObligation Contractual Obligation USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 287.33M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 27.16M 2023-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030807
us-gaap CostOfRevenue Cost of Revenue USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 19.15M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap DebtRelatedCommitmentFeesAndDebtIssuanceCosts Debt Related Commitment Fees and Debt Issuance Costs USD 1.97M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030807
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 3.42M 2024-02-29 2024 FY 10-K 2025-03-03 0000950170-25-030807
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 155.35M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 20.42M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 99.35M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 210,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 22.69M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.22M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 148.18M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 7.17M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap Depreciation Depreciation USD 835,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap Dividends Dividends USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.158 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.055 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.023 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 664,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.053 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.022 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 2.75M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058634
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -29.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 47.83M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 5.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 6.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 5.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 5.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 380,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -1,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277531
us-gaap GrossProfit Gross Profit USD 43,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 22.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -29.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 835,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 378,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 3.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 136,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -22,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -1.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -73,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net USD 38,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 841,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 3.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap InventoryNet Inventory, Net USD 73,000 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap LeaseCost Lease, Cost USD 6.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 47.83M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 22.78M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 5.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 6.08M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 6.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 5.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 5.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 20.42M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap Liabilities Liabilities USD 79.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 65.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap LiabilitiesCurrent Liabilities, Current USD 17.34M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 29.23M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 4.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -554,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -54.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -30.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -140.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 28.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap NotesPayableCurrent Notes Payable, Current USD 413,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap NotesPayableToBankNoncurrent Notes Payable to Bank, Noncurrent USD 30.16M 2024-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030807
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap OperatingExpenses Operating Expenses USD 58.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -58.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap OperatingLeaseCost Operating Lease, Cost USD 5.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 31.06M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 5.22M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 24.67M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 25.52M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.127 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 685,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 132,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 555,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 400,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030807
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.85M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 554,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 2.75M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219373
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 2.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 103.69M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 2.07M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 383,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 28.43M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030807
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 280,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 4.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -30.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 5.13M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.69M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 75,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030807
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 41.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030807
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 4.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -586.73M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 1.40M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 16.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 7.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 129,679 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 13,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -13.22M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 12 2026-10-02 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 287.33M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 213,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 100.28M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 425,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 280,000 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2024-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030807
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD 1.74M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 28.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap VariableLeaseCost Variable Lease, Cost USD 682,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-121793
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 13.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 13.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458318

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →